Martin Leblanc

Martin is co-founder and was recently named Vice-Chairman of CellCarta Biosciences after having been its CEO for the past 16 years. Formerly known as Caprion Biosciences and headquartered in Montreal, Canada, CellCarta is a leading global provider of specialized precision medicine laboratory services to the biopharmaceutical industry. CellCarta operates globally with over 1000 employees in its 11 facilities located in Canada, USA, Belgium, Australia and China. Under Martin’s leadership the company has sustained strong organic growth, concluded 10 company mergers and acquisitions, and has been successively managed under the ownership of 4 leading healthcare private equity firms.

Martin is also the chairman of the board of Montreal InVivo and a member of numerous private company and not-for-profit boards. Prior to Caprion, Martin was a management consultant for McKinsey & Company as well as co-owner and senior executive of another successful biotech venture, Advanced Bioconcept.

Martin earned his bachelor’s degree in Economics from the University of Moncton prior to completing an M.A. in Economics and Politics at Oxford University as a Rhodes Scholar.